These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30133723)

  • 1. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies.
    Johnston J; Lantos JD; Goldenberg A; Chen F; Parens E; Koenig BA;
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S2-S6. PubMed ID: 30133723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Genomic Sequencing Can Offer Universal Newborn Screening Programs.
    Powell CM
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S18-S19. PubMed ID: 30133725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Newborn Sequencing to Advance Understanding of the Natural History of Disease.
    Holm IA
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S45-S46. PubMed ID: 30133736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Legal Dimensions of Genomic Sequencing in Newborn Screening.
    Zacharias RL; Smith ME; King JS
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S39-S41. PubMed ID: 30133728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq.
    Ross LF; Clayton EW
    Pediatrics; 2019 Dec; 144(6):. PubMed ID: 31719124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic sequencing for newborn screening: current perspectives and challenges.
    Shah N; Brlek P; Bulić L; Brenner E; Škaro V; Skelin A; Projić P; Shah P; Primorac D
    Croat Med J; 2024 Jun; 65(3):261-267. PubMed ID: 38868972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial Interests, the Technological Imperative, and Advocates: Three Forces Driving Genomic Sequencing in Newborns.
    Pereira S; Clayton EW
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S43-S44. PubMed ID: 30133724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Families' Experiences with Newborn Screening: A Critical Source of Evidence.
    Grob R; Roberts S; Timmermans S
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S29-S31. PubMed ID: 30133722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. My Diagnostic Odyssey-A Call to Expand Access to Genomic Testing for the Next Generation.
    Michelson J
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S32-S34. PubMed ID: 30133734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Era, New Strategies: Education and Communication Strategies to Manage Greater Access to Genomic Information.
    Lewis MA; Bonhomme N; Bloss CS
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S25-S27. PubMed ID: 30133727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn Sequencing in Genomic Medicine and Public Health.
    Berg JS; Agrawal PB; Bailey DB; Beggs AH; Brenner SE; Brower AM; Cakici JA; Ceyhan-Birsoy O; Chan K; Chen F; Currier RJ; Dukhovny D; Green RC; Harris-Wai J; Holm IA; Iglesias B; Joseph G; Kingsmore SF; Koenig BA; Kwok PY; Lantos J; Leeder SJ; Lewis MA; McGuire AL; Milko LV; Mooney SD; Parad RB; Pereira S; Petrikin J; Powell BC; Powell CM; Puck JM; Rehm HL; Risch N; Roche M; Shieh JT; Veeraraghavan N; Watson MS; Willig L; Yu TW; Urv T; Wise AL
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28096516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baby genome screening: paving the way to genetic discrimination?
    Seidel MG
    BMJ; 2017 Jul; 358():j3294. PubMed ID: 28729238
    [No Abstract]   [Full Text] [Related]  

  • 13. Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes.
    Howard HC; Knoppers BM; Cornel MC; Wright Clayton E; Sénécal K; Borry P; ; ;
    Eur J Hum Genet; 2015 Dec; 23(12):1593-600. PubMed ID: 25626707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical and Psychosocial Issues in Whole Genome Sequencing (WGS) for Newborns.
    Lantos JD
    Pediatrics; 2019 Jan; 143(Suppl 1):S1-S5. PubMed ID: 30600264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.
    Borghesi A; Mencarelli MA; Memo L; Ferrero GB; Bartuli A; Genuardi M; Stronati M; Villani A; Renieri A; Corsello G;
    Ital J Pediatr; 2017 Nov; 43(1):100. PubMed ID: 29100554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eugenics Redux: "Reproductive Benefit" as a Rationale for Newborn Screening.
    Paul DB
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S12-S13. PubMed ID: 30133732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
    Sayeed SA
    Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening.
    Berg JS; Powell CM
    Cold Spring Harb Perspect Med; 2015 Oct; 5(12):. PubMed ID: 26438605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Parents Really Obligated to Learn as Much as Possible about Their Children's Genomes?
    Johnston J; Juengst E
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S14-S15. PubMed ID: 30133729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.